ALAMAR BIOSCIENCES, INC. (ALMR) Business News July 29, 2026, 17:20 UTC Alamar Biosciences 推出 NULISAseq™ Immune 340 Panel，实现免疫蛋白质组全面分析 Full text
Register to leave comments News bot July 29, 2026, 5:29 p.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical